Calliditas Therapeutics AB (CALT) Stock Balance Sheet
NASDAQ:CALT • US13124Q1067
Current stock price
40.0001 USD
-0.16 (-0.4%)
Last:
| MRQ (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 797.28M | 973.73M | 1.25B | 955.51M | 996.30M | |||
| Receivables | 222.59M | 188.19M | 80.99M | 11.34M | 22.80M | |||
| Inventories | 40.16M | 20.43M | 3.65M | 889.00K | 0.00 | |||
| Other Current Assets | 94.44M | 92.80M | 78.47M | 45.03M | 17.75M | |||
| Total Current Assets | 1.15B | 1.28B | 1.41B | 1.01B | 1.04B | |||
| Non-Current Assets | ||||||||
| PPE Net | 59.36M | 54.24M | 31.92M | 39.61M | 5.41M | |||
| Investments And Advances | 27.21M | 7.64M | 6.85M | 3.92M | 2.23M | |||
| Goodwill | 47.81M | 48.58M | 45.78M | N/A | N/A | |||
| Intangibles | 423.86M | 430.75M | 438.06M | 399.42M | 461.37M | |||
| Other Non-Current Assets | 34.51M | 26.32M | 13.80M | 4.20M | 600.00K | |||
| Total Non-Current Assets | 592.74M | 584.09M | 540.77M | 447.14M | 469.60M | |||
| TOTAL ASSETS | 1.75B | 1.86B | 1.95B | 1.46B | 1.51B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 12.54M | 10.37M | 9.59M | 3.91M | |||
| Accrued Expenses | 252.14M | 280.63M | 136.45M | 53.55M | 41.39M | |||
| Accounts Payable | 151.01M | 100.56M | 160.40M | 67.97M | 53.83M | |||
| Other Current Liabilities | 26.62M | 13.42M | 18.01M | 4.33M | 6.50M | |||
| Total Current Liabilities | 429.78M | 407.14M | 325.23M | 135.45M | 105.62M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 1.01B | 966.60M | 728.82M | 213.22M | 878.00K | |||
| Deferred Taxes/Income | 36.70M | 41.64M | 39.75M | 30.86M | 80.00M | |||
| Other Non-Current Liabilities | 165.67M | 109.06M | 92.90M | 72.11M | 63.66M | |||
| Total Non-Current Liabilities | 1.21B | 1.12B | 861.48M | 316.18M | 190.34M | |||
| TOTAL LIABILITIES | 1.64B | 1.52B | 1.19B | 451.63M | 295.96M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | N/A | -2.31B | -1.84B | -1.45B | -924.69M | |||
| Additional Paid In Capital | N/A | 2.64B | 2.59B | 2.46B | 2.13B | |||
| Minority Interest | N/A | 0.00 | 0.00 | 0.00 | 45.81M | |||
| Common Shares | 2.40M | 2.38M | 2.38M | 2.09M | 2.00M | |||
| Other Shareholders' Equity | 104.39M | -5.23M | 9.31M | -1.00K | N/A | |||
| Shares Outstanding | 27.18M | 27.01M | 27.01M | 26.34M | 25.13M | |||
| Tangible Book Value per Share | -6.76 | -2.69 | 5.26 | 11.63 | 15.00 | |||
| Total Shareholders' Equity | 106.79M | 334.81M | 766.26M | 1.01B | 1.21B | |||
| TOTAL LIABILITIES AND EQUITY | 1.75B | 1.86B | 1.95B | 1.46B | 1.51B | |||
| Statistics | ||||||||
| Debt/Equity | 9.44 | 2.89 | 0.95 | 0.21 | 0.00 | |||
| Current Ratio | 2.69 | 3.13 | 4.34 | 7.48 | 9.82 | |||
| Return On Assets (ROA) | -27.49% | -25.07% | -21.11% | -34.27% | -28.78% | |||
| Return On Equity (ROE) | -449.82% | -139.24% | -53.80% | -49.62% | -35.81% | |||
All data in SEK , ROIC based on taxRate of 0.21